For Patients
Find essential information here about ovarian cancer prevention, risk factors, and steps to take if you’ve been newly diagnosed, in treatment or navigating life beyond.
The Rivkin Center Has Joined OCRA
The Rivkin Center Has Joined OCRA
This historic collaboration unites two respected organizations committed to advancing research for better treatments and a cure for ovarian cancer.
Expanding Research Through Partnership
Ovarian Cancer Research Alliance (OCRA), the world’s leading ovarian and gynecologic cancer nonprofit, is proud to announce that the Rivkin Center for Ovarian Cancer Research has combined with OCRA.
Please explore the resources below to learn more about the support and tools available from OCRA.
Support & Resources
OCRA is here for you and your family to answer questions or connect you with resources to help you and offer support.
Research
OCRA has awarded more than 400 grants and invested $140 million in ovarian cancer and related gynecologic cancer research initiatives, becoming the largest global charity devoted to ovarian and related gynecologic cancer research in the world.
Center for Public Policy
OCRA advocates on Capitol Hill to improve research and education, drug and diagnostic safety, and access to quality care for all members of the ovarian and gynecologic cancer community, having helped secure $3.8 billion in federal research and education funding since inception..
Get Involved
Help us get one step closer to a cure. There are so many ways to lend a hand and improve the lives of patients and families impacted by ovarian and all gynecologic cancers.
OCRA Rivkin Family SummeRun
Join thousands of participants of all ages and fitness levels at Seattle’s Seward Park to raise awareness and fund critical research for ovarian cancer. Registration opens in early April.
About
OCRA is the leading organization in the world fighting ovarian and all gynecologic cancers on all fronts while supporting patients and their families.
Related Topics
New AI Accelerator Grant Captures Health and Science Media Attention
OCRA is excited to see the work fueled by our new AI Accelerator Grant resonating with a broad array of audiences. Since the Global Ovarian Cancer Research Consortium announced the inaugural AI Accelerator Grant on February 19, coverage has appeared across health, science, and business media outlets. The $1 million global research award—with an additional … Continued
The Overview: February 2026
The Global Ovarian Cancer Research Consortium and its inaugural AI Accelerator Grant have been making waves across health, science, and business media, reflecting widespread interest in what this work could mean for patients. The $1 million global research grant, plus an additional $1 million in compute support from Microsoft’s AI for Good Lab, will fund … Continued
Ovarian Cancer Research Alliance Honors Researchers with 2025 Rosalind Franklin and Schreiber Prizes
Recognizing Advances in Ovarian Cancer Research and Immunotherapy Ovarian Cancer Research Alliance (OCRA) announced today the winners of two prizes recognizing exceptional accomplishments in ovarian cancer research. David Huntsman, MD, FRCPC, FCCMG, was awarded the 2025 Rosalind Franklin Prize for Excellence in Ovarian Cancer Research for his findings that have profoundly impacted the treatment of … Continued